Skip to main content
. 2019 Sep 11;4(5):e001705. doi: 10.1136/bmjgh-2019-001705

Table 3.

Comparison of insulin glargine mark-ups between countries

China
(Hubei)
China
(Shaanxi)
Ghana India (Haryana) Indonesia China (Shaanxi)
Lantus Solostar pen Lantus cartridge Lantus Solostar pen Basalin cartridge
Import Import Import Import Import Import Import Import Local Local
Region Capital Capital District Capital District Capital Capital Capital District
Sector Public Public Private Private Private Public Private Public Private
MSP (US$) 20.7 21.4 10.8 18.4 4.9 22.1 22.1 20.2 20.2
Stage 1 (%) 0.0 0.0 7.0 7.0 0.0 0.0 0.0 0.0 0.0
Stage 2 (%) 33.5 33.5 8.0 8.0 27.6 26.8 182.0 0.0 0.0
Stage 3 (%) 8.7 5.3 25.0 25.0 8.7 15.0 15.0 11.8 0.5
Stage 4 (%) 15.0 15.0 56.0 23.9 13.1 26.0 15.0 15.0 9.3
Stage 5 (%) 0.0 0.0* 0.0 0.0 5.3 7.9 8.7 0.0 0.0*
Cumulative total (%) 66.9 61.6 125.4 79.0 65.1 98.3 305.4 28.6 9.8
Final price (US$) 34.5 34.5 24.7 32.7 8.0 43.8 89.5 26.0 22.2

In some cases more than one glargine product was surveyed, but only a single representative product is shown unless major differences were evident. Note that some products are complete pens and others are cartridges.

Stage 1: insurance and freight. Stage 2: clearance charges. Stage 3: wholesale mark-ups. Stage 4: retail mark-ups. Stage 5: sales tax/value-added tax (VAT).

*VAT incorporated in stage 4.

MSP, manufacturer's selling price.